A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer
Clinical trial NCT06738966 · RECRUITING
Trial details
- NCT number
- NCT06738966
- Sponsor
- Shanghai Best-Link Bioscience, LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-10
- Primary completion
- 2026-02-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.